ANKERX PTY LTD was an Australian Private Company registered in Victoria. The ABN was cancelled on the 29 October 2024 and is not currently registered for GST. It was registered with ASIC on the 27 May 2021 as an Australian proprietary company, Limited by Shares and was de-registered on the 13 October 2024.
ANKERX PTY LTD was an Australian biotechnology company focused on the development of novel therapies targeting inflammatory lung diseases, including asthma, chronic obstructive pulmonary disease, and pulmonary fibrosis. The business was based on proprietary small molecule research developed through a long-term collaboration between academic researchers from the Monash Institute of Pharmaceutical Sciences and the University of South Australia. The entity is currently de-registered.
We weren't able to find any other public information on this company.
| Name | Status |
|---|---|
|
ANKERE THERAPEUTICS Since 25 October 2021 |
27 November 2025 |
| Entity ID | Name | Status |
|---|
WGEA workforce data loads when this section is in view.